 Effect recombinant human granulocyte-macrophage colony-stimulating factor administration lymphocyte subsets patients refractory aplastic anemia Human recombinant granulocyte-macrophage colony-stimulating factor rhGM-CSF patients refractory aplastic anemia AA effect rhGM-CSF therapy lymphocyte phenotype proliferative responses mitogen phytohemagglutinin Candida tetanus toxoid natural killer NK activity circulating Samples baseline rhGM-CSF administration absolute number lymphocytes constant first period significant increase second period increase prominent cells cells Detailed investigation lymphocyte subsets increase markers HLA-DR transferrin receptor treatment course evidence lymphoid cell activation NK cell activity treatment proliferative responses Candida antigen tetanus toxoid unaffected mechanism GM-CSF activation increase absolute lymphoid cell number cells decrease NK cytotoxicity implication immune changes relation resistance remains